Black Diamond Therapeutics, Inc.
BDTX
$2.02
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 70.00M | 70.00M | 70.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 0.00 | 70.00M | 70.00M | 70.00M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.00 | 0.00 | 70.00M | 70.00M | 70.00M |
| SG&A Expenses | 16.43M | 15.86M | 16.57M | 18.58M | 20.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.56M | 45.92M | 50.13M | 58.14M | 65.30M |
| Operating Income | -44.56M | -45.92M | 19.87M | 11.86M | 4.71M |
| Income Before Tax | -42.56M | -43.21M | 22.37M | 21.50M | 14.44M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -42.56 | -43.21 | 22.37 | 21.50 | 14.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.56M | -43.21M | 22.37M | 21.50M | 14.44M |
| EBIT | -44.56M | -45.92M | 19.87M | 11.86M | 4.71M |
| EBITDA | -44.35M | -45.65M | 20.20M | 12.20M | 5.05M |
| EPS Basic | -0.74 | -0.76 | 0.40 | 0.38 | 0.25 |
| Normalized Basic EPS | -0.39 | -0.39 | 0.33 | 0.23 | 0.15 |
| EPS Diluted | -0.75 | -0.76 | 0.38 | 0.36 | 0.23 |
| Normalized Diluted EPS | -0.39 | -0.39 | 0.32 | 0.22 | 0.14 |
| Average Basic Shares Outstanding | 228.62M | 228.06M | 227.49M | 227.00M | 226.58M |
| Average Diluted Shares Outstanding | 228.62M | 228.06M | 228.50M | 228.01M | 227.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |